Dr. Dayan Goodenowe launches international health tracking trial

Dr. Dayan Goodenowe has secured approval for a large observational trial in the U.S. and Canada to study how comprehensive wellness programming relates to health, function and quality of life. The study could help researchers measure health itself more scientifically and may inform future public health planning.

Why it matters: - The trial is designed to connect wellness participation with measurable changes in health, function, and quality of life. - Researchers will also examine how those changes relate to disease incidence, outcomes, and health economics. - The study could help fill a research gap in how to scientifically measure health itself, not just disease. - The findings may inform future public health planning.

What happened: - Neuroscientist and biochemical researcher Dr. Dayan Goodenowe announced approval of a large epidemiological tracking trial. - The study will evaluate associations between participation in comprehensive wellness programming and outcomes in adults and children. - Enrollment is approved in the U.S. and Canada. - The trial is sponsored by Dr. Goodenowe Research LLC and registered at ClinicalTrials.gov as NCT07832981. - More information is available through the study listing and the research program page. - Dr. Goodenowe is the principal investigator.

The details: - The study is observational, not interventional. - Researchers will not assign participants to a wellness program. - Researchers will not direct participants to use specific nutritional supplements. - The study will prospectively follow participants over time. - The team will evaluate associations among wellness program participation, supplement use, and other health and lifestyle factors. - The study will collect objective and participant-reported measures. - Measures include neurological and cognitive function, body composition, cardiovascular and respiratory function, mobility and physical function, lifestyle, sleep, fatigue, stress, and quality of life. - Participants may elect to provide blood samples for laboratory analysis, including biochemical measurements. - Repeated assessments will create a longitudinal dataset. - The dataset will be used to identify patterns across biochemical, physiological, functional, cognitive, and quality-of-life measures. - Study locations include the Restorative Health Center in Temecula, California, and Lakeview Regional Wellness Centre in Moose Jaw, Saskatchewan. - Adults and children age 2 and older may be eligible. - The study accepts healthy volunteers. - Eligibility requirements and additional study information are available from the research team.

Between the lines: - The trial reflects a shift toward studying wellness and pre-disease states rather than waiting for symptoms to appear. - The design is meant to track multiple dimensions of health at once instead of focusing on a single disease or intervention. - The approach may produce a broader real-world dataset than a traditional clinical trial because it follows people in routine settings. - Dr. Goodenowe has spent more than 30 years studying human health, aging, and neurological function, and his patented technologies have been used to study biochemical patterns across tens of thousands of individuals. - Dr. Goodenowe is founder and CEO of Prodrome Science and Perpetual Health.

What's next: - Researchers will begin enrolling participants at the listed locations. - Baseline and follow-up assessments will track changes in health over time. - The research team will use the results to evaluate which measurable changes are associated with improved or diminished health and function. - The study may generate evidence for future wellness and public health strategies.

The bottom line: - Dr. Goodenowe is betting that long-term tracking of wellness participation can help quantify health in ways traditional medicine has not.